| scholarly article | Q13442814 |
| P50 | author | Raymond F. Schinazi | Q7298769 |
| Christina Gavegnano | Q125272221 | ||
| P2093 | author name string | Baek Kim | |
| Edward M Kennedy | |||
| P2860 | cites work | Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response | Q24338296 |
| SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx | Q24605940 | ||
| SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates | Q24624362 | ||
| Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein | Q24635842 | ||
| Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy. | Q52021616 | ||
| Rapid MHC-II antigen presentation of HIV type 1 by human dendritic cells. | Q53543523 | ||
| The CD16+ Monocyte Subset Is More Permissive to Infection and Preferentially Harbors HIV-1 In Vivo | Q58003915 | ||
| Assessing the relative efficacy of antiretroviral activity of different drugs on macrophages | Q80977227 | ||
| CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1 | Q28646859 | ||
| Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies | Q28751900 | ||
| Physiological concentrations of purines and pyrimidines | Q29616721 | ||
| A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs | Q34145909 | ||
| Antiretroviral therapy in macrophages: implication for HIV eradication | Q34298792 | ||
| Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase | Q34313399 | ||
| Ribonucleoside triphosphates as substrate of human immunodeficiency virus type 1 reverse transcriptase in human macrophages | Q34386057 | ||
| Macrophages: a crucial reservoir for human immunodeficiency virus in the body. | Q34427702 | ||
| Mutagenicity and pausing of HIV reverse transcriptase during HIV plus-strand DNA synthesis | Q34798628 | ||
| Pulsed stable isotope labeling of amino acids in cell culture uncovers the dynamic interactions between HIV-1 and the monocyte-derived macrophage | Q35025824 | ||
| The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages. | Q35040074 | ||
| Abundant non-canonical dUTP found in primary human macrophages drives its frequent incorporation by HIV-1 reverse transcriptase | Q35107515 | ||
| Monocyte/macrophage traffic in HIV and SIV encephalitis | Q35213772 | ||
| Human immunodeficiency virus infects human seminal vesicles in vitro and in vivo | Q35474074 | ||
| Depletion of CD4⁺ T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques | Q35484743 | ||
| The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers--a review and hyp | Q35636412 | ||
| Antiretroviral monocyte efficacy score linked to cognitive impairment in HIV. | Q37024994 | ||
| Cellular reservoirs of HIV-1 and their role in viral persistence | Q37196089 | ||
| Effect of the O6 substituent on misincorporation kinetics catalyzed by DNA polymerases at O(6)-methylguanine and O(6)-benzylguanine | Q38292985 | ||
| Mechanistic studies of early pausing events during initiation of HIV-1 reverse transcription | Q38334633 | ||
| Simultaneous quantification of intracellular natural and antiretroviral nucleosides and nucleotides by liquid chromatography-tandem mass spectrometry | Q38583674 | ||
| Circulating monocytes are not a major reservoir of HIV-1 in elite suppressors | Q38748887 | ||
| Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy | Q39685944 | ||
| Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus | Q40037960 | ||
| Failure to clear intra-monocyte HIV infection linked to persistent neuropsychological testing impairment after first-line combined antiretroviral therapy | Q42130105 | ||
| Different pattern of activity of inhibitors of the human immunodeficiency virus in lymphocytes and monocyte/macrophages | Q43664017 | ||
| Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus | Q44177453 | ||
| Modification of human immunodeficiency virus type 1 reverse transcriptase to target cells with elevated cellular dNTP concentrations | Q45419490 | ||
| T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen | Q45760106 | ||
| Analysis of nucleotide insertion and extension at 8-oxo-7,8-dihydroguanine by replicative T7 polymerase exo- and human immunodeficiency virus-1 reverse transcriptase using steady-state and pre-steady-state kinetics | Q45762771 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 625983 | |
| P577 | publication date | 2012-07-01 | |
| P1433 | published in | Molecular Biology International | Q26841791 |
| P1476 | title | The Impact of Macrophage Nucleotide Pools on HIV-1 Reverse Transcription, Viral Replication, and the Development of Novel Antiviral Agents | |
| P478 | volume | 2012 |
| Q42152706 | AZT resistance alters enzymatic properties and creates an ATP-binding site in SFVmac reverse transcriptase |
| Q36081148 | Alterations in P-Glycoprotein Expression and Function Between Macrophage Subsets |
| Q34632979 | Anti-tat Hutat2:Fc mediated protection against tat-induced neurotoxicity and HIV-1 replication in human monocyte-derived macrophages |
| Q41451997 | Cellular pharmacology and potency of HIV-1 nucleoside analogs in primary human macrophages |
| Q58092929 | Differential extracellular, but similar intracellular, disposition of two tenofovir formulations in the male genital tract |
| Q37270321 | Diverse fates of uracilated HIV-1 DNA during infection of myeloid lineage cells. |
| Q33606917 | GTP activator and dNTP substrates of HIV-1 restriction factor SAMHD1 generate a long-lived activated state |
| Q38773755 | Human Immunodeficiency Virus Infection and Host Defense in the Lungs |
| Q21245040 | Identification and characterization of naturally occurring splice variants of SAMHD1 |
| Q42176551 | Kinetic variations between reverse transcriptases of viral protein X coding and noncoding lentiviruses |
| Q36086379 | Nef Is Dispensable for Resistance of Simian Immunodeficiency Virus-Infected Macrophages to CD8+ T Cell Killing |
| Q37311408 | Restricted 5'-end gap repair of HIV-1 integration due to limited cellular dNTP concentrations in human primary macrophages |
| Q90609678 | Seminal Tenofovir Concentrations, Viral Suppression, and Semen Quality With Tenofovir Alafenamide, Compared With Tenofovir Disoproxil Fumarate (Spanish HIV/AIDS Research Network, PreEC/RIS 40) |
| Q38290524 | Single-Stranded Nucleic Acids Bind to the Tetramer Interface of SAMHD1 and Prevent Formation of the Catalytic Homotetramer |
| Q26823236 | The macrophage: a therapeutic target in HIV-1 infection |
| Q27698300 | The mechanism of substrate-controlled allosteric regulation of SAMHD1 activated by GTP |
| Q64971881 | Transcriptional Profiling Suggests Extensive Metabolic Rewiring of Human and Mouse Macrophages during Early Interferon Alpha Responses. |
Search more.